|
Please Wait . .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
. .
.
|
|
Main|Search|PHGKB
Last
Posted:
Nov 08, 2018
- Test Detects One in a Million Cancer Cells
R Voelker, JAMA, November 6, 2018
- Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
Pugh Trevor J et al. Cancer genetics 2018 Oct
- NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia.
Yi Eun Sang et al. Cancer research and treatment : official journal of Korean Cancer Association 2018 Jul 50(3) 872-882
- The First Genome Surgeons- Scientists have built tools that can cheaply and easily edit DNA. Now they are preparing to bring them into the clinic to cure disease.
A Bleicher, the Medium, October 23, 2018
- Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
Xu Xinjie et al. Cancer genetics 2018 Oct
- Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
Kim Borahm et al. The Journal of molecular diagnostics : JMD 2018 Oct
- Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies.
Yang Shuanghui et al. Molecular therapy. Nucleic acids 2018 Sep 13164-175
- CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.
Mollanoori Hasan et al. Human immunology 2018 Sep
- FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma,
FDA, September 28, 2018
- Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy: Progress Continues.
Diouf Barthelemy et al. Clinical pharmacology and therapeutics 2018 Sep
more
Information in Various Databases
From
Tier Table Database
CDC Office of Public Health Genomics (OPHG) conducts horizon
scanning (a systematic research method to find and follow novel
technologies appearing in the literature) to identify and track
the progress of genomic tests as they move from research into
clinical and public health practice. As an aid in organizing
horizon scanning results, OPHG ranks genomic tests, and family
health history applications, by levels of evidence. See detail.
Get Records
From
Genomics &
Health Impact Scan Database
This database includes published
scientific literature on evidence-based translation of genomic
discoveries into improved health care and disease prevention
that have a potential impact on population health.
Get Records
From
Genomics &
Health Impact Scan Database
This database includes published
scientific literature on evidence-based translation of genomic
discoveries into improved health care and disease prevention
that have a potential impact on population health.
Get Records
From
Genomics &
Health Impact Scan Database
This database includes published
scientific literature on evidence-based translation of genomic
discoveries into improved health care and disease prevention
that have a potential impact on population health.
Get Records
From
Genomics &
Health Impact Scan Database
This database includes published
scientific literature on evidence-based translation of genomic
discoveries into improved health care and disease prevention
that have a potential impact on population health.
Get Records
From
Genomics &
Health Impact Scan Database
This database includes published
scientific literature on evidence-based translation of genomic
discoveries into improved health care and disease prevention
that have a potential impact on population health.
Get Records
From
Genomics &
Health Impact Scan Database
This database includes published
scientific literature on evidence-based translation of genomic
discoveries into improved health care and disease prevention
that have a potential impact on population health.
Get Records
From
From Advanced
Molecular Detection Clips Database
This database includes published
scientific literature, popular press articles, tools, and
databases on the emerging role of pathogen genomics and
host-pathogen interactions in infectious disease control and
prevention. It includes information on methods, evolution and
pathogenicity, detection and diagnosis, outbreaks, epidemiology
and transmission, antimicrobials, and vaccines and host-pathogen
interactions.
Get Records
From
GRANTOMICS
GRANTOMICS is a search engine and analysis tool for grant information associated with published literature on evidence-based translation of genomics discoveries into improved health care and disease prevention, and human genome epidemiology.The literature information is from Genomics & Health Impact Scan Database and HuGE Literature Finder Database.The grant information is extracted from the grant data in PubMed records and NIH RePORT. Grant information can be searched by disease/condition, environmental risk factors, or gene of study and other free text, and a simple analysis can be performed.
Get Records
From
GWAS Catalog
The Catalog is a quality controlled, manually curated, literature-derived collection of all published genome-wide association studies.
Get Records
From
NIH The Genetic
Testing Registry
The Genetic Testing Registry (GTR®)
provides a central location for voluntary submission of genetic
test information by providers. The scope includes the test's
purpose, methodology, validity, evidence of the test's usefulness,
and laboratory contacts and credentials. The overarching goal of
the GTR is to advance the public health and research into the
genetic basis of health and disease.
From
NIH OMIM
OMIM is a comprehensive, authoritative
compendium of human genes and genetic phenotypes that is freely
available and updated daily.
From
PubMed Clinical Queries
PubMed Clinical Queries is an utility offered by PubMed to search scientific literature in specific clinical research areas
From
PharmGKB
The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships.
From
PubMed
PubMed comprises more than 27 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Disclaimer: Articles listed in the Public
Health Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented.
The selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included
in the update, or persons quoted therein, are strictly their own and
are in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
